IMMEDIATE GRAFT
Perfect for small bony defects
Immediate Graft is a combination of our perio size OsseoConduct beta tricalcium phosphate granules and Socket Graft. It is supplied in small quantities for grafting small bony defects. Immediate Graft is ready to use with no mixing required.
Immediate Graft should be stored in the refrigerator until use.
This product contains no human or animal tissue.
Strengthen Your Practice
Immediate Graft will change your practice when your patients realize our technology is available to them. Your patients now have a choice between a chemically pure, FDA cleared bone graft or the frequently off-putting choice of cadaver tissue. Resorbable synthetics and autografts are the only bone grafts that produce normal bone. Normal bone is the only type of bone that has been shown to support an implant for a lifetime.
Immediate Graft provides the organic and inorganic molecules a bone needs in order to regrow faster, stronger, healthier, and more vital. Our patented SL Factor in our bone graft material targets the osteoblasts within the patient’s bone, initiating the bone regeneration process. Our product has been classified as a drug device and this the drug contained in this product has been shown to stimulate bone formation.
How Does SL Factor Work?
SteinerBio has the only bone grafts on the market that contain a drug that changes the physiology of a bone’s osteoblasts to stimulate osteogenesis. SL Factor, our patented organic compound, enters through the membrane of the osteoblasts and results in the following metabolic activities:
- SL Factor is absorbed by the osteoblasts
- SL Factor activates over 300 genes that stimulate the process of bone formation
- BMP2 and RUNX2 production increases two-fold and reduces osteoclast formation by inhibiting the production of RANK ligand
- Osteocalcin accumulation is enhanced in the extracellular matrix resulting in excellent mineralization
- While stored in the osteoblast, SL Factor continues to stimulate bone growth after the synthetic matrix has been resorbed
- Adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression is inhibited
- Inflammation is reduced by inhibiting prostaglandin synthesis
MEMBER:
American Society for Bone and Mineral Research (ASBMR)
Tissue Engineering and Regenerative Medicine International Society (TERMIS)
American Academy of Implant Dentistry (AAID)